OTCMKTS:CURLF Curaleaf (CURLF) Stock Price, News & Analysis $2.92 +0.09 (+3.18%) (As of 09/13/2024 08:54 PM ET) Add Compare Share Share Today's Range$2.80▼$2.9350-Day Range$2.75▼$4.3452-Week Range$2.51▼$6.40Volume246,100 shsAverage Volume732,812 shsMarket Capitalization$1.89 billionP/E RatioN/ADividend YieldN/APrice Target$6.25 Stock AnalysisStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Get Curaleaf alerts: Email Address Curaleaf MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside114.0% Upside$6.25 Price TargetShort InterestBearish0.96% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.39Based on 4 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.24) to ($0.15) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.12 out of 5 stars 3.5 Analyst's Opinion Consensus RatingCuraleaf has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageCuraleaf has only been the subject of 2 research reports in the past 90 days.Read more about Curaleaf's stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted0.96% of the outstanding shares of Curaleaf have been sold short.Short Interest Ratio / Days to CoverCuraleaf has a short interest ratio ("days to cover") of 5.8.Change versus previous monthShort interest in Curaleaf has recently increased by 12.97%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldCuraleaf does not currently pay a dividend.Dividend GrowthCuraleaf does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CURLF. Previous Next 1.3 News and Social Media Coverage News SentimentCuraleaf has a news sentiment score of 0.39. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.65 average news sentiment score of Consumer Discretionary companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Curaleaf this week, compared to 4 articles on an average week.Search InterestOnly 4 people have searched for CURLF on MarketBeat in the last 30 days. This is a decrease of -64% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Curaleaf to their MarketBeat watchlist in the last 30 days. This is a decrease of -86% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Curaleaf insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 0.03% of the stock of Curaleaf is held by institutions.Read more about Curaleaf's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Curaleaf are expected to grow in the coming year, from ($0.24) to ($0.15) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Curaleaf is -7.49, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Curaleaf is -7.49, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCuraleaf has a P/B Ratio of 1.78. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Brownstone ResearchIntroducing the PerceptronOn Wednesday, September 25, I’m putting on my first crypto event in two years to unveil: the Perceptron. This is my AI project that I first conceived of shortly after I recommended Nvidia back in 2016.Just click here to register. About Curaleaf Stock (OTCMKTS:CURLF)Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. It also provides hemp-based products and cannabinoids, such as cannabidiol and cannabigerol. In addition, the company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. The company is headquartered in New York, New York.Read More CURLF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CURLF Stock News HeadlinesSeptember 16 at 3:01 AM | americanbankingnews.comCuraleaf Holdings, Inc. (OTCMKTS:CURLF) Sees Large Growth in Short InterestSeptember 11, 2024 | seekingalpha.comCuraleaf Has Multiple Catalysts For A Significant RallySeptember 16, 2024 | Brownstone Research (Ad) My big AI project…On Wednesday, September 25, I’m putting on my first crypto event in two years to unveil: the Perceptron. This is my AI project that I first conceived of shortly after I recommended Nvidia back in 2016.September 9, 2024 | barrons.comWeed ETFs Soar on Trump Comments. Why They’re Not for the Faint-Hearted.September 7, 2024 | americanbankingnews.comCuraleaf (OTCMKTS:CURLF) Stock Price Down 5.6%September 5, 2024 | msn.comOhio's Cannabis Sales Reach $44M As New Customers Just Keep Coming And Demand Is Not SlowingSeptember 3, 2024 | morningstar.comCannabis an 'increasingly bipartisan' issue as Trump signals support: analystAugust 30, 2024 | finance.yahoo.com2 Million Brits Are Self Medicating With Cannabis, The Market Soars 10% Monthly - Will National Health Service Prescriptions Catch Up?September 16, 2024 | Brownstone Research (Ad) My big AI project…On Wednesday, September 25, I’m putting on my first crypto event in two years to unveil: the Perceptron. This is my AI project that I first conceived of shortly after I recommended Nvidia back in 2016.August 30, 2024 | prnewswire.comCuraleaf Launches Innovative JAMS Remix Fast-Acting Ratio JelliesAugust 28, 2024 | uk.news.yahoo.comUkraine claims control of nearly 500 square miles of Russian territory - as it tests home-made ballistic missileAugust 28, 2024 | msn.com'I Got Marijuana Legal In Ohio' Says Rapper Afroman Toasting Fellow Ohioans With Pink And Gold GobletAugust 27, 2024 | morningstar.comCannabis stocks drop as DEA sets drug-rescheduling hearing after November electionAugust 27, 2024 | finance.yahoo.comPot stocks fall as US DEA pushes cannabis reclassification hearing to DecemberAugust 27, 2024 | finance.yahoo.comDEA sets date for marijuana rescheduling for after electionAugust 27, 2024 | morningstar.comAscend Wellness becomes third cannabis company to jettison its chief executive this monthAugust 20, 2024 | news.yahoo.comCuraleaf dispensary opens on Chili AvenueAugust 14, 2024 | prnewswire.comCuraleaf Announces the Opening of New Dispensary in Destin, FloridaSee More Headlines Receive CURLF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Curaleaf and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/07/2024Today9/16/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorConsumer Discretionary Industry Medicinals & botanicals Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:CURLF CUSIPN/A CIK1756770 Webwww.curaleaf.com Phone781-451-0351FaxN/AEmployees5,650Year FoundedN/APrice Target and Rating Average Stock Price Target$6.25 High Stock Price Target$6.25 Low Stock Price Target$6.25 Potential Upside/Downside+114.0%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.39) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-281,200,000.00 Net Margins-18.59% Pretax Margin-9.21% Return on Equity-14.75% Return on Assets-5.19% Debt Debt-to-Equity Ratio0.83 Current Ratio1.09 Quick Ratio0.50 Sales & Book Value Annual Sales$1.35 billion Price / Sales1.40 Cash Flow$0.15 per share Price / Cash Flow18.94 Book Value$1.64 per share Price / Book1.78Miscellaneous Outstanding Shares647,860,000Free FloatN/AMarket Cap$1.89 billion OptionableNot Optionable Beta0.83 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Boris Alexis Jordan (Age 58)Executive Chairman Comp: $1.19MMr. Matthew S. DarinChief Executive OfficerMr. Joseph F. Lusardi (Age 50)Executive Vice-Chairman Comp: $728.12kMr. Edward Kremer (Age 52)Chief Financial Officer Comp: $764.02kMr. James S. Shorris (Age 63)Chief Compliance Officer Ms. Tracy BradySenior Vice President of Corporate CommunicationsMs. Kate LynchExecutive Vice President of MarketingMs. Tyneeha RiversChief People OfficerMr. Jessie KaterSenior Vice President of Innovation, Research & DevelopmentMore ExecutivesKey CompetitorsElanco Animal HealthNYSE:ELANLantheusNASDAQ:LNTHRevolution MedicinesNASDAQ:RVMDAscendis Pharma A/SNASDAQ:ASNDZealand Pharma A/SOTCMKTS:ZLDPFView All Competitors CURLF Stock Analysis - Frequently Asked Questions How have CURLF shares performed this year? Curaleaf's stock was trading at $4.06 at the beginning of 2024. Since then, CURLF stock has decreased by 28.1% and is now trading at $2.92. View the best growth stocks for 2024 here. How were Curaleaf's earnings last quarter? Curaleaf Holdings, Inc. (OTCMKTS:CURLF) posted its earnings results on Wednesday, August, 7th. The company reported ($0.06) earnings per share for the quarter, missing the consensus estimate of ($0.05) by $0.01. The company earned $342.29 million during the quarter, compared to the consensus estimate of $344.57 million. Curaleaf had a negative net margin of 18.59% and a negative trailing twelve-month return on equity of 14.75%. How do I buy shares of Curaleaf? Shares of CURLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:CURLF) was last updated on 9/16/2024 by MarketBeat.com Staff From Our PartnersBiden's Executive Order, Dems Digital Money Legislation, First Step ToDonald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans...Monetary Gold | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredIntroducing the PerceptronOn Wednesday, September 25, I’m putting on my first crypto event in two years to unveil: the Perceptron. Th...Brownstone Research | SponsoredBREAKING NEWS: AI Tech Now Used to Stop School ShootersTwo seconds. That's all it takes for Knightscope's Automated Gunshot Detection to notify authorities and map a...Market JAR | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredPrepare for a Recession Unlike Any OtherDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dav...American Hartford Gold Group | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Curaleaf Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Curaleaf With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.